Revision to EMA Alzheimer’s Trial Guideline

The European Medicines Agency Guidelines on the clinical investigation of medicines for the treatment of Alzheimer's Disease (AD) were last updated in 2018. The Agency has recently published a concept paper concerning future revision of these Guidelines.

‍ The revisions are, in part, the result of recent advances in the field of AD